|
|
|
|
|
16.06.26 - 21:24
|
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? (24/7 Wall St.)
|
|
|
Moderna (NASDAQ:MRNA) stock is jumping again. Shares are up 9% today, trading near $57 in the Tuesday afternoon session. That extends a remarkable 2026 run for the mRNA pioneer. The move pushes Moderna stock to +94% year to date (YTD), easily the best performance in the major vaccine cohort. By comparison, Pfizer (NYSE:PFE) stock is ... Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?...
|
|
|
|
|
15.06.26 - 23:30
|
Top Research Reports for Pfizer, Altria & Newmont Corp. (Zacks)
|
|
|
Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Altria Group, Inc. (MO) and Newmont Corp. (NEM), as well as two micro-cap stocks, Koil Energy Solutions, Inc. (KLNG) and Stratus Properties Inc. (STRS)....
|
|
|
|
|
|
|
|
|
15.06.26 - 07:15
|
SINOPHARM Establishes Strategic Partnership with Pfizer, Inc. (AAStocks)
|
|
|
SINOPHARM (01099.HK) has recently formally established a strategic partnership with Pfizer, Inc. (PFE.US). The two parties will focus on the upgraded market promotion of Diflucan (fluconazole sodium chloride injection/fluconazole capsules), as well as in-depth cooperation on service enhancements for Pfizer's future new products.......
|
|
|
|
|
|
|
|
|
|
|
12.06.26 - 09:18
|
Dividenden-Liebling Pfizer: Absage an Merz (Der Aktionaer)
|
|
|
Der US-amerikanische Pharma-Riese Pfizer hat große Investitionspläne für Deutschland. Doch diese stehen nun offenbar auf dem Prüfstand. Der Grund dafür sind die geplanten härteren Sparvorgaben in der Bundesrepublik, auf die bereits auch schon die Pharma-Konzerne Eli Lilly und Boehringer Ingelheim reagiert haben....
|
|
|
|
|
|
|
11.06.26 - 20:24
|
A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25 (24/7 Wall St.)
|
|
|
At $25.60, Pfizer (NYSE:PFE) sits in Hold territory on Wall Street's consensus. The headline 6.7% dividend yield is reason to pause rather than pounce. A payout that fat usually reflects a market pricing in trouble, and the under-the-radar concern is whether stretched operating cash flow can fund both the dividend and the debt stack from ... A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
